Results 61 to 70 of about 7,562 (197)

Extensive morphea profunda with autoantibodies and benign tumors: A rare case report

open access: yesIndian Dermatology Online Journal, 2012
The term deep morphea describes a variant of morphea (localised scleroderma) in which inflammation and sclerosis are found in the deep dermis, panniculus, fascia or superficial muscle. It is sometimes associated with autoantibodies. We report the case of
Leelavathy Budamakuntla   +1 more
doaj   +1 more source

A Guide to Screening for Autoimmune Diseases in Patients With Vulvar Lichen Sclerosus

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 3, Page 135-141, May 2025.
ABSTRACT Background The aetiology of vulvar lichen sclerosus (VLS) remains unknown. However, there is evidence that in addition to a genetic predisposition, autoimmunity contributes to the pathogenesis. Objectives The objective of this study was to determine the prevalence of autoimmune disease and positive autoantibody serology in patients with VLS ...
Annabel Guttentag   +5 more
wiley   +1 more source

Fat Graft as Regenerative Treatment of Facial Manifestations of Systemic Sclerosis: A Systematic Review on the Role of Adipose Tissue‐Derived Stem Cells and on Surgical Outcomes to Define a New Standardised Injection Protocol

open access: yesWound Repair and Regeneration, Volume 33, Issue 3, May/June 2025.
ABSTRACT Facial symptoms of systemic sclerosis (SSc)—such as reduced skin elasticity, fibrosis and microstomy—significantly impact quality of life. In recent years, autologous fat grafting has emerged as a promising treatment for these issues, but determining the optimal timing and techniques for fat injection remains a challenge for surgeons.
A. Arena   +10 more
wiley   +1 more source

Twardzina ograniczona pęcherzowa – przedstawienie dwóch przypadków, trudności terapeutyczne

open access: yesPrzegląd Dermatologiczny, 2011
tissue disease. The main symptoms are atrophy and fibrosis of the connectivetissue stroma, preceded by changes in the small blood vessels.Pathogenesis of morphea is still unknown.
Dorota Krasowska   +5 more
doaj  

How I explore ... the skin functional involvement in scleroderma [PDF]

open access: yes, 2013
peer reviewedScleroderma refers to distinct clinical presentations sharing in common a sclerotic process most often clinically obvious on the skin. The involvement possibly affects the skin alone in morphea or in combination with internal lesions in ...
Andre, B.   +6 more
core  

Parry Romberg Syndrome with localized scleroderma: a case report [PDF]

open access: yes, 2014
Parry Romberg syndrome(PRS) is a rare acquired poorly understood neurocutaneous syndrome of unknown etiology characterized by slow progressive atrophic changes commonly affecting one half of the face. The exact incidence and etiology towards the syndrome
Gupta, Nikita   +3 more
core   +1 more source

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi   +12 more
wiley   +1 more source

Grundlagen und Wirkprinzipien von wassergefiltertem Infrarot A (wIRA) in Bezug zur Wundheilung [PDF]

open access: yes, 2006
The experience of the pleasant heat of the sun in moderate climatic zones arises from the filtering of the heat radiation of the sun by water vapor in the atmosphere of the earth.
Hoffmann, Gerd
core   +1 more source

Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives

open access: yesExperimental Dermatology, Volume 34, Issue 4, April 2025.
ABSTRACT JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events. Ruxolitinib 1.5% cream is a selective topical JAK1 and JAK2 inhibitor, which has recently been approved by EMA and MHRA for treating non‐segmental vitiligo, while being FDA‐approved ...
Marco Spadafora   +5 more
wiley   +1 more source

Morphea on the breast and pregnancy

open access: yesThe Pan African Medical Journal, 2013
Morphea is an uncommon, indolent, dermatologic disorder characterized by dermal fibrosis and collagen deposition. Its appearance during pregnancy is rare.
Loubna Benchat, Fatima Zahra Mernissi
doaj   +1 more source

Home - About - Disclaimer - Privacy